Cargando…

Genomic profiling and sites of metastasis in non-small cell lung cancer

BACKGROUND: We investigated the biological predisposition to site of metastasis in patients with NSCLC based on their molecular profiling and program death ligand PD-L1 status. We sought to identify any association between metastatic site and molecular profile in NSCLC patients. METHODS: This was a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Kok Hoe, Sridhar, Arthi, Lin, Ji Zheng, Jafri, Syed Hassan Raza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523019/ https://www.ncbi.nlm.nih.gov/pubmed/37771447 http://dx.doi.org/10.3389/fonc.2023.1212788

Ejemplares similares

ADVANCED LUNG CANCER INFLAMMATORY INDEX AS A PROGNOSTIC MARKER FOR OXYGEN REQUIREMENT IN PATIENTS ADMITTED WITH SARS-COV-2 INFECTION
por: SRIDHAR, ARTHI, et al.
Publicado: (2021)

Intracardiac Metastasis From Non-Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2015)

Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis
por: Zhu, Tianhao, et al.
Publicado: (2020)

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases
por: Abdulhaleem, Mohammed, et al.
Publicado: (2023)

CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer
por: Liang, Nan, et al.
Publicado: (2023)

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients
por: Jafri, Syed Hasan Raza, et al.
Publicado: (2015)

Prediction of bone metastasis in non-small cell lung cancer based on machine learning
por: Li, Meng-Pan, et al.
Publicado: (2023)

Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer
por: He, Kewen, et al.
Publicado: (2022)

Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
por: Wang, Yongsheng, et al.
Publicado: (2021)

Hippocampal Metastasis Rate Based on Non-Small Lung Cancer TNM Stage and Molecular Markers
por: Ahn, Sung Jun, et al.
Publicado: (2022)

Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer
por: Kim, Kangjoon, et al.
Publicado: (2023)

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment
por: Dong, Changqing, et al.
Publicado: (2022)

NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
por: Peng, Lu, et al.
Publicado: (2021)

Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer
por: Wang, Yang, et al.
Publicado: (2023)

EGFR and ERBB2 exon 20 insertion/duplication in advanced non–small cell lung cancer: genomic profiling and clinicopathologic features
por: Sompallae, Ramakrishna R., et al.
Publicado: (2023)

Screening for renal cell carcinoma in renal transplant recipients: a single-centre retrospective study
por: Yohannan, Binoy, et al.
Publicado: (2023)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Pankova, Olga V., et al.
Publicado: (2021)

Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
por: Zhang, Wei, et al.
Publicado: (2022)

Multi-Omics Profiling Suggesting Intratumoral Mast Cells as Predictive Index of Breast Cancer Lung Metastasis
por: Zhang, Leyi, et al.
Publicado: (2022)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Response of Pembrolizumab Alone for Non-small Cell Lung Cancer With Brain Metastasis: A Case Report and Literature Review
por: Marvin, Eric A., et al.
Publicado: (2020)

Survival Outcomes of Patients With Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
por: Li, Ning, et al.
Publicado: (2022)

The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung Cancer
por: Asano, Yohei, et al.
Publicado: (2022)

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
por: Zhang, Wei, et al.
Publicado: (2022)

Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung Cancer
por: Li, Ji, et al.
Publicado: (2021)

Development of Nomograms for Predicting Lymph Node Metastasis and Distant Metastasis in Newly Diagnosed T1-2 Non-Small Cell Lung Cancer: A Population-Based Analysis
por: Qi, Yiming, et al.
Publicado: (2021)

Metabolomics profiling in prediction of chemo-immunotherapy efficiency in advanced non-small cell lung cancer
por: Mei, Lihong, et al.
Publicado: (2023)

Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022)

Preoperative Prediction of Lymph Node Metastasis in Patients With Early-T-Stage Non-small Cell Lung Cancer by Machine Learning Algorithms
por: Wu, Yijun, et al.
Publicado: (2020)

Iodine-125 brachytherapy treatment for newly diagnosed brain metastasis in non-small cell lung cancer: A biocentric analysis
por: Yang, Lili, et al.
Publicado: (2022)

Case report: Rechallenge with EGFR–TKIs after immunotherapy in EGFR–mutated non–small cell lung cancer with leptomeningeal metastasis
por: Qian, Chunfa, et al.
Publicado: (2022)

Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China
por: Lv, Weize, et al.
Publicado: (2021)

Profiling of 520 Candidate Genes in 50 Surgically Treated Chinese Small Cell Lung Cancer Patients
por: Yuan, Ting, et al.
Publicado: (2021)

The Evolution of BRAF Activation in Non-Small-Cell Lung Cancer
por: Zhang, Longyao, et al.
Publicado: (2022)

Efficacy of radiomics model based on the concept of gross tumor volume and clinical target volume in predicting occult lymph node metastasis in non-small cell lung cancer
por: Zeng, Chao, et al.
Publicado: (2023)

Deep learning of bone metastasis in small cell lung cancer: A large sample-based study
por: Chen, Qing, et al.
Publicado: (2023)

Breast Metastasis From a Non-small Cell Lung Cancer: A Case Report
por: Guerrouaz, Mohammed Amine, et al.
Publicado: (2020)

Clinicopathological Profile of Non-small Cell Lung Cancer and the Changing Trends in Its Histopathology: Experience From a Tertiary Care Cancer Center in Kashmir, India
por: Mir, Mohmad H, et al.
Publicado: (2023)

Down Regulation of the Expression of ELMO3 by COX2 Inhibitor Suppresses Tumor Growth and Metastasis in Non-Small-Cell Lung Cancer
por: Pan, Cailong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_js7cm4e2cq73ck9h980v14lrpv